PROGNOSYS BIOSCIENCES, INC. — Department of Health and Human Services SBIR Phase II: DESCRIPTION (provided by applicant): There is a need for new technologies to enable the an

PROGNOSYS BIOSCIENCES, INC. — SBIR Phase II award from Department of Health and Human Services.

Amount
$2,118,754
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase II
Solicitation
PA10-050
NAICS
Place of performance
CA
Period

Description

DESCRIPTION (provided by applicant): There is a need for new technologies to enable the analysis of the proteome. We propose to develop a novel technology for analyzing protease activity. Proteases are involved in the regulation of essential cellular processes and misregulation of proteolytic activity is involved in many diseases such as neurodegeneration, cardiovascular diseases, arthritis, Alzheimer's disease, cancer, and infectious diseases. PUBLIC HEALTH RELEVANCE: The protease activity profilingtechnology we are developing is useful for identifying new protease drug targets for drug development. It would help to elucidate the functional roles of specific proteases and may result in advances in the diagnosis and treatment of disease.